CXCL16 and CXCR6 are upregulated in psoriasis and mediate cutaneous recruitment of human CD8+ T cells

Journal of Investigative Dermatology

Volumn 132, Issue 3 PART 1, 2012, Pages 626-634

  Günther, Claudia ^a,b   Carballido Perrig, Nicole ^b,c   Kaesler, Susanne ^d   Carballido, José M ^b,c   Biedermann, Tilo ^b,d  

^a DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^b Novartis Institutes for BioMedical Research Vienna   (Austria)

^c NOVARTIS PHARMA AG   (Switzerland)

^d UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CXCR6; CXCL16 CHEMOKINE; ETANERCEPT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN PRESENTING CELL; ARTICLE; CALCIUM TRANSPORT; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL HOMING; CELL MIGRATION; CHEMOTAXIS; CLINICAL ARTICLE; CONTROLLED STUDY; DENDRITIC CELL; DOWN REGULATION; HUMAN; HUMAN CELL; KERATINOCYTE; MONOCYTE; MOUSE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; PSORIASIS; UPREGULATION;

EID: 84857046318     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1038/jid.2011.371     Document Type: Article

References (47)

1. Abel S, Hundhausen C, Mentlein R et al. (2004) The transmembrane CXCchemokine ligand 16 is induced by IFN-gamma and TNF-alpha and shed by the activity of the disintegrin-like metalloproteinase ADAM10. J Immunol 172:6362-72 (Pubitemid 38621245)
2. Andrew DP, Ruffing N, Kim CH et al. (2001) C-C chemokine receptor 4 expression defines a major subset of circulating nonintestinal memory T cells of both Th1 and Th2 potential. J Immunol 166:103-11 (Pubitemid 32038422)
3. Aust G, Kamprad M, Lamesch P et al. (2005) CXCR6 within T-helper (Th) and T-cytotoxic (Tc) type 1 lymphocytes in Graves' disease (GD). Eur J Endocrinol 152:635-43 (Pubitemid 40575810)
4. Austin LM, Ozawa M, Kikuchi T et al. (1999) The majority of epidermal T cells in Psoriasis vulgaris lesions can produce type 1 cytokines, interferon-g, interleukin-2, and tumor necrosis factor-alpha, defining TC1 (cytotoxic T lymphocyte) and TH1 effector populations: A type 1 differentiation bias is also measured in circulating blood T cells in psoriatic patients. J Invest Dermatol 113:752-9
5. Baker BS, Griffiths CE, Lambert S et al. (1988) The effects of cyclosporine A on T lymphocyte and dendritic cell subpopulations in psoriasis. Transplant Proc 20:72-7
6. Biedermann T, Schwarzler C, Lametschwandtner G et al. (2002) Targeting CLA/ E-selectin interactions prevents CCR4-mediated recruitment of human Th2 memory cells to human skin in vivo. Eur J Immunol 32:3171-80 (Pubitemid 35414874)
7. Bos JD, Hagenaars C, Das PK et al. (1989) Predominance of ''memory'' T cells (CD4+, CDw29+) over ''naive'' T cells (CD4+, CD45R+) in both normal and diseased human skin. Arch Dermatol Res 281:24-30 (Pubitemid 19064135)
8. Buchau AS, Gallo RL (2007) Innate immunity and antimicrobial defense systems in psoriasis. Clin Dermatol 25:616-24 (Pubitemid 350087608)
9. Campbell JJ, Haraldsen G, Pan J et al. (1999) The chemokine receptor CCR4 in vascular recognition by cutaneous but not intestinal memory T cells. Nature 400:776-80 (Pubitemid 29399540)
10. Carballido JM, Aversa G, Kaltoft K et al. (1997) Reversal of human allergic T helper 2 responses by engagement of signaling lymphocytic activation molecule. J Immunol 159:4316-21 (Pubitemid 127470588)
11. Chang JC, Smith LR, Froning KJ et al. (1994) CD8+ T cells in psoriatic lesions preferentially use T-cell receptor V beta 3 and/or V beta 13.1 genes. Proc Natl Acad Sci USA 91:9282-6
12. Di Cesare A, Di Meglio P, Nestle FO (2009) The IL-23/Th17 axis in the immunopathogenesis of psoriasis. J Invest Dermatol 129: 1339-50
13. Fife DJ, Waller JM, Jeffes EW et al. (2007) Unraveling the paradoxes of HIVassociated psoriasis: A review of T-cell subsets and cytokine profiles. Dermatol Online J 13:4
14. Friedrich M, Krammig S, Henze M et al. (2000) Flow cytometric characterization of lesional T cells in psoriasis: Intracellular cytokine and surface antigen expression indicates an activated, memory/effector type 1 immunophenotype. Arch Dermatol Res 292:519-21 (Pubitemid 32112810)
15. Gough PJ, Garton KJ, Wille PT et al. (2004) A disintegrin and metalloproteinase 10-mediated cleavage and shedding regulates the cell surface expression of CXC chemokine ligand 16. J Immunol 172:3678-85 (Pubitemid 38337951)
16. Griffiths CE, Barker JN (2007) Pathogenesis and clinical features of psoriasis. Lancet 370:263-71 (Pubitemid 47069537)
17. Gudjonsson JE, Johnston A, Sigmundsdottir H et al. (2004) Immunopathogenic mechanisms in psoriasis. Clin Exp Immunol 135:1-8 (Pubitemid 38067920)
18. Hofnagel O, Luechtenborg B, Plenz G et al. (2002) Expression of the novel scavenger receptor SR-PSOX in cultured aortic smooth muscle cells and umbilical endothelial cells. Arterioscler Thromb Vasc Biol 22:710-1 (Pubitemid 34408758)
19. Homey B, Eu-Nosjean MC, Wiesenborn A et al. (2000) Up-regulation of macrophage inflammatory protein-3 a /CCL20 and CC chemokine receptor 6 in psoriasis. J Immunol 164:6621-32 (Pubitemid 30408849)
20. Huang Y, Zhu XY, Du MR et al. (2008) Human trophoblasts recruited T lymphocytes and monocytes into decidua by secretion of chemokine CXCL16 and interaction with CXCR6 in the first-trimester pregnancy. J Immunol 180:2367-75
21. Ikaheimo I, Tiilikainen A, Karvonen J et al. (1996) HLA risk haplotype Cw6,DR7,DQA1.*0201 and HLA-Cw6 with reference to the clinical picture of psoriasis vulgaris. Arch Dermatol Res 288:363-5 (Pubitemid 26232087)
22. Kim CH, Kunkel EJ, Boisvert J et al. (2001a) Bonzo/CXCR6 expression defines type 1-polarized T-cell subsets with extralymphoid tissue homing potential. J Clin Invest 107:595-601 (Pubitemid 32205180)
23. Kim CH, Rott L, Kunkel EJ et al. (2001b) Rules of chemokine receptor association with T cell polarization in vivo. J Clin Invest 108:1331-9 (Pubitemid 33107761)
24. Kryczek I, Bruce AT, Gudjonsson J et al. (2008) Induction of IL-17+ T cell trafficking and development by IFN-g: Mechanism and pathological relevance in psoriasis. J Immunol 181:4733-41
25. Matloubian M, David A, Engel S et al. (2000) A transmembrane CXC chemokine is a ligand for HIV-coreceptor Bonzo. Nat Immunol 1:298-304
26. Minami M, Kume N, Shimaoka T et al. (2001) Expression of SR-PSOX, a novel cell-surface scavenger receptor for phosphatidylserine and oxidized LDL in human atherosclerotic lesions. Arterioscler Thromb Vasc Biol 21:1796-800 (Pubitemid 34219784)
27. Nanki T, Shimaoka T, Hayashida K et al. (2005) Pathogenic role of the CXCL16-CXCR6 pathway in rheumatoid arthritis. Arthritis Rheum 52:3004-14 (Pubitemid 41447079)
28. Oh ST, Schramme A, Tilgen W et al. (2009) Overexpression of CXCL16 in lesional psoriatic skin. Dermatoendocrinol 1:114-8
29. Ortega C, Fernandez A, Carrillo JM et al. (2009) IL-17-producing CD8+ T lymphocytes from psoriasis skin plaques are cytotoxic effector cells that secrete Th17-related cytokines. J Leukoc Biol 86:435-43
30. Paukkonen K, Naukkarinen A, Horsmanheimo M (1992) The development of manifest psoriatic lesions is linked with the invasion of CD8 + T cells and CD11c + macrophages into the epidermis. Arch Dermatol Res 284:375-9 (Pubitemid 23009892)
31. Rot A, von Andrian UH (2004) Chemokines in innate and adaptive host defense: Basic chemokinese grammar for immune cells. Annu Rev Immunol 22:891-928 (Pubitemid 38680444)
32. Rottman JB, Smith TL, Ganley KG et al. (2001) Potential role of the chemokine receptors CXCR3, CCR4, and the integrin alphaEbeta7 in the pathogenesis of psoriasis vulgaris. Lab Invest 81:335-47 (Pubitemid 32245066)
33. Ruth JH, Haas CS, Park CC et al. (2006) CXCL16-mediated cell recruitment to rheumatoid arthritis synovial tissue and murine lymph nodes is dependent upon the MAPK pathway. Arthritis Rheum 54:765-78
34. Scholz F, Schulte A, Adamski F et al. (2007) Constitutive expression and regulated release of the transmembrane chemokine CXCL16 in human and murine skin. J Invest Dermatol 127:1444-55 (Pubitemid 46763000)
35. Schroder JM, Harder J (2006) [Innate antimicrobial peptides in the skin]. Med Sci (Paris) 22:153-7 (Pubitemid 43242070)
36. Shimaoka T, Kume N, Minami M et al. (2000) Molecular cloning of a novel scavenger receptor for oxidized low density lipoprotein, SR-PSOX, on macrophages. J Biol Chem 275:40663-6 (Pubitemid 32054881)
37. Shimaoka T, Nakayama T, Kume N et al. (2003) Cutting edge: SR-PSOX/CXC chemokine ligand 16 mediates bacterial phagocytosis by APCs through its chemokine domain. J Immunol 171:1647-51 (Pubitemid 36966446)
38. Shimaoka T, Nakayama T, Fukumoto N et al. (2004) Cell surface-anchored SR-PSOX/CXC chemokine ligand 16 mediates firm adhesion of CXC chemokine receptor 6-expressing cells. J Leukoc Biol 75:267-74 (Pubitemid 38174584)
39. Sigmundsdottir H, Gudjonsson JE, Jonsdottir I et al. (2001) The frequency of CLA+ CD8+ T cells in the blood of psoriasis patients correlates closely with the severity of their disease. Clin Exp Immunol 126:365-9 (Pubitemid 32995154)
40. Teraki Y, Miyake A, Takebayashi R et al. (2004) Homing receptor and chemokine receptor on intraepidermal T cells in psoriasis vulgaris. Clin Exp Dermatol 29:658-63 (Pubitemid 39573660)
41. Thomas SY, Hou R, Boyson JE et al. (2003) CD1d-restricted NKT cells express a chemokine receptor profile indicative of Th1-type inflammatory homing cells. J Immunol 171:2571-80 (Pubitemid 37025568)
42. Tohyama M, Sayama K, Komatsuzawa H et al. (2007) CXCL16 is a novel mediator of the innate immunity of epidermal keratinocytes. Int Immunol 19:1095-102 (Pubitemid 47434242)
43. Unutmaz D, Xiang W, Sunshine MJ et al. (2000) The primate lentiviral receptor Bonzo/STRL33 is coordinately regulated with CCR5 and its expression pattern is conserved between human and mouse. J Immunol 165:3284-92
44. van der Voort R, van Lieshout AW, Toonen LW et al. (2005) Elevated CXCL16 expression by synovial macrophages recruits memory T cells into rheumatoid joints. Arthritis Rheum 52:1381-91 (Pubitemid 40663928)
45. van Lieshout AW, van der Voort R, Toonen LW et al. (2009) Regulation of CXCL16 expression and secretion by myeloid cells is not altered in rheumatoid arthritis. Ann Rheum Dis 68:1036-43
46. Vissers WH, Arndtz CH, Muys L et al. (2004) Memory effector (CD45RO+) and cytotoxic (CD8+) T cells appear early in the margin zone of spreading psoriatic lesions in contrast to cells expressing natural killer receptors, which appear late. Br J Dermatol 150:852-9 (Pubitemid 38903516)
47. Wilbanks A, Zondlo SC, Murphy K et al. (2001) Expression cloning of the STRL33/BONZO/TYMSTRligand reveals elements of CC, CXC, and CX3C chemokines. J Immunol 166:5145-54 (Pubitemid 32280729)